163 related articles for article (PubMed ID: 21699785)
1. Mesenchymal stem cells promote formation of colorectal tumors in mice.
Tsai KS; Yang SH; Lei YP; Tsai CC; Chen HW; Hsu CY; Chen LL; Wang HW; Miller SA; Chiou SH; Hung MC; Hung SC
Gastroenterology; 2011 Sep; 141(3):1046-56. PubMed ID: 21699785
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway.
Hsu HS; Lin JH; Hsu TW; Su K; Wang CW; Yang KY; Chiou SH; Hung SC
Lung Cancer; 2012 Feb; 75(2):167-77. PubMed ID: 21802163
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice.
Huang WH; Chang MC; Tsai KS; Hung MC; Chen HL; Hung SC
Oncogene; 2013 Sep; 32(37):4343-54. PubMed ID: 23085755
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism.
Poynter JA; Herrmann JL; Manukyan MC; Wang Y; Abarbanell AM; Weil BR; Brewster BD; Meldrum DR
J Am Coll Surg; 2011 Aug; 213(2):253-60. PubMed ID: 21546276
[TBL] [Abstract][Full Text] [Related]
5. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
6. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
[TBL] [Abstract][Full Text] [Related]
7. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
8. Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling.
Zhang X; Hu F; Li G; Li G; Yang X; Liu L; Zhang R; Zhang B; Feng Y
Cell Death Dis; 2018 Jan; 9(2):25. PubMed ID: 29348540
[TBL] [Abstract][Full Text] [Related]
9. Limitation of in vivo models investigating angiogenesis in breast cancer.
Gehmert S; Gehmert S; Bai X; Klein S; Ortmann O; Prantl L
Clin Hemorheol Microcirc; 2011; 49(1-4):519-26. PubMed ID: 22214723
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
[TBL] [Abstract][Full Text] [Related]
11. Survival of bone marrow-derived mesenchymal stem cells in a xenotransplantation model.
Wang Y; Chen X; Armstrong MA; Li G
J Orthop Res; 2007 Jul; 25(7):926-32. PubMed ID: 17415789
[TBL] [Abstract][Full Text] [Related]
12. Characterization and biodistribution of human mesenchymal stem cells transduced with lentiviral-mediated BMP2.
Choi KS; Ahn SY; Kim TS; Kim J; Kim BG; Han KH; Ban SJ; Kim HS; Choi Y; Lim CJ
Arch Pharm Res; 2011 Apr; 34(4):599-606. PubMed ID: 21544725
[TBL] [Abstract][Full Text] [Related]
13. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.
Xue J; Li X; Jiao S; Wei Y; Wu G; Fang J
Gastroenterology; 2010 Feb; 138(2):606-15. PubMed ID: 19786027
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.
Cui X; Liu J; Bai L; Tian J; Zhu J
Cancer Sci; 2014 Jan; 105(1):64-71. PubMed ID: 24168060
[TBL] [Abstract][Full Text] [Related]
15. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient osteogenic differentiation of human mesenchymal stem cells by eradication of STAT3 signaling.
Levy O; Ruvinov E; Reem T; Granot Y; Cohen S
Int J Biochem Cell Biol; 2010 Nov; 42(11):1823-30. PubMed ID: 20691278
[TBL] [Abstract][Full Text] [Related]
18. Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells.
Yamaoka E; Hiyama E; Sotomaru Y; Onitake Y; Fukuba I; Sudo T; Sueda T; Hiyama K
Int J Oncol; 2011 Jul; 39(1):5-11. PubMed ID: 21573488
[TBL] [Abstract][Full Text] [Related]
19. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells.
De Luca A; Gallo M; Aldinucci D; Ribatti D; Lamura L; D'Alessio A; De Filippi R; Pinto A; Normanno N
J Cell Physiol; 2011 Aug; 226(8):2131-8. PubMed ID: 21520065
[TBL] [Abstract][Full Text] [Related]
20. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells.
Menon LG; Picinich S; Koneru R; Gao H; Lin SY; Koneru M; Mayer-Kuckuk P; Glod J; Banerjee D
Stem Cells; 2007 Feb; 25(2):520-8. PubMed ID: 17053212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
